• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The reality of drug use in COPD: the European perspective.

作者信息

Rudolf M

机构信息

Ealing Hospital, London, UK.

出版信息

Chest. 2000 Feb;117(2 Suppl):29S-32S. doi: 10.1378/chest.117.2_suppl.29s.

DOI:10.1378/chest.117.2_suppl.29s
PMID:10673471
Abstract

COPD guidelines provide advice about the appropriate use of various medications in treating patients with this condition. Comparisons of drug therapy as recommended by these guidelines with what is actually prescribed by both primary care physicians and specialist pulmonologists in a number of European countries can be examined in a variety of ways. Nonadherence to guidelines and differences between countries are caused by a number of factors, including varying degrees of misdiagnosis and different national attitudes to various classes of drugs.

摘要

相似文献

1
The reality of drug use in COPD: the European perspective.
Chest. 2000 Feb;117(2 Suppl):29S-32S. doi: 10.1378/chest.117.2_suppl.29s.
2
Chronic obstructive pulmonary disease.
Clin Evid. 2002 Jun(7):1344-57.
3
Recommendations for the management of COPD.
Chest. 2000 Feb;117(2 Suppl):23S-8S. doi: 10.1378/chest.117.2_suppl.23s.
4
[Drug therapy of COPD].[慢性阻塞性肺疾病的药物治疗]
Nihon Naika Gakkai Zasshi. 2001 May 10;90(5):807-12.
5
[Drug therapy of chronic phase in chronic obstructive pulmonary disease].
Nihon Naika Gakkai Zasshi. 1995 May 10;84(5):735-9.
6
[Inhalational corticosteroids in COPD. THe ISOLDE Study (Inhaled Steroids in Obstructive Lung Disease in Europe)].
Internist (Berl). 2001 Jul;42(7):1050-2.
7
[COPD therapy in coronary heart disease patients. How safe are bronchodilators?].[冠心病患者的慢性阻塞性肺疾病治疗。支气管扩张剂有多安全?]
MMW Fortschr Med. 2009 Oct 29;151(44):22.
8
[Stage appropriate therapy for COPD].
Internist (Berl). 2006 Sep;47(9):901-2, 904-7. doi: 10.1007/s00108-006-1701-0.
9
[Recent progress on the therapy for chronic obstructive pulmonary disease (COPD)--usefulness and practice of the step-by-step pharmacologic therapy].
Nihon Rinsho. 1999 Sep;57(9):2035-40.
10
[Treatment of COPD in primary care].[基层医疗中慢性阻塞性肺疾病的治疗]
Arch Bronconeumol. 2000 Mar;36(3):167.

引用本文的文献

1
Validity of a portable spirometer in the communities of China.一种便携式肺活量计在中国社区的有效性。
BMC Pulm Med. 2022 Mar 5;22(1):80. doi: 10.1186/s12890-022-01872-9.
2
Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD).北非肺病专家对 2017 年全球慢性阻塞性肺疾病(COPD)倡议(GOLD)稳定期 COPD 药物治疗指南(PTGs)的依从性。
Biomed Res Int. 2020 Feb 28;2020:1031845. doi: 10.1155/2020/1031845. eCollection 2020.
3
Missed diagnosis and overtreatment of COPD among smoking primary care population in Central Greece: old problems persist.
希腊中部吸烟的初级保健人群中慢性阻塞性肺疾病(COPD)的漏诊和过度治疗:老问题依然存在。
Int J Chron Obstruct Pulmon Dis. 2018 Feb 5;13:487-498. doi: 10.2147/COPD.S147628. eCollection 2018.
4
Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study.希腊慢性阻塞性肺疾病(COPD)现患病例和新发病例的特征:GOLDEN研究
Int J Chron Obstruct Pulmon Dis. 2015 Jul 20;10:1371-82. doi: 10.2147/COPD.S81468. eCollection 2015.
5
Health and social impacts of COPD and the problem of under-diagnosis.慢性阻塞性肺疾病的健康和社会影响以及诊断不足的问题。
Multidiscip Respir Med. 2014 Dec 6;9(1):63. doi: 10.1186/2049-6958-9-63. eCollection 2014.
6
The AIMAR recommendations for early diagnosis of chronic obstructive respiratory disease based on the WHO/GARD model*.基于世界卫生组织/全球哮喘防治创议(WHO/GARD)模式的慢性阻塞性呼吸道疾病早期诊断的艾马尔建议*
Multidiscip Respir Med. 2014 Sep 3;9(1):46. doi: 10.1186/2049-6958-9-46. eCollection 2014.
7
Do symptoms predict COPD in smokers?吸烟者的症状能预测 COPD 吗?
Chest. 2010 Jun;137(6):1345-53. doi: 10.1378/chest.09-2681. Epub 2010 Apr 2.
8
Guidelines versus clinical practice in antimicrobial therapy for COPD.慢性阻塞性肺疾病抗菌治疗的指南与临床实践。
Lung. 2010 Apr;188(2):173-8. doi: 10.1007/s00408-009-9216-9.
9
Bronchodilators in COPD: impact of beta-agonists and anticholinergics on severe exacerbations and mortality.慢性阻塞性肺疾病中的支气管扩张剂:β受体激动剂和抗胆碱能药物对严重急性加重和死亡率的影响。
Int J Chron Obstruct Pulmon Dis. 2007;2(1):11-8. doi: 10.2147/copd.2007.2.1.11.
10
Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids.慢性阻塞性肺疾病临床结局的系统评价:β受体激动剂与抗胆碱能药物及吸入性糖皮质激素的使用比较
Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):219-30. doi: 10.1385/CRIAI:31:2:219.